Women undergoing hormone replacement therapy (HRT) can raise their risk of developing ovarian cancer by as much as 40 percent, according to the latest study.
The researchers at the Oxford University conducted the study.
The findings have been hailed by the cancer charities, who have recommended more and more women to know the risks of HRT ahead of finally opting for the treatment.
Liz Aram, a resident of southwest London, had underwent HRT procedure five years ago and now she has been diagnosed with ovarian cancer and presently is in remission.
Aram says if she had any idea about the dire consequences of the HRT, she probably would have never gone for the procedure and lived longer with the symptoms.
UK-based Cancer Research’s Fiona Osgun said the previous research works had already shown HRT use for more than five years raises the risk of ovarian cancer in women. But the new comprehensive study shows there is a high risk of developing the cancer type even if the HRT is used for less time than five years.
And if a woman stops using HRT, her ovarian cancer risk can drop over time.
HRT is also effective in lowering the symptoms of menopause.
According to Osgun, there are several factors that compel a woman to go for HRT procedure or discontinue its use.
“We have always advised the lowest effective dose of HRT for the shortest period of time,” said Sarah Branch, deputy director of Vigilance and Risk Management of Medicines Division of MHRA.
Branch further said that they will be evaluating the study’s findings and its implications for use in shorter term period.
The findings of the study were detailed in journal The Lancet.